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SENSITIZATION POTENTIALS AND IMMUNOLOGIC SPECIFICITIES OF 
NEOMYCINS 
CHOONG W. CHUNG, M.D., PHD., AND THEOPHILUS R. CARSON, B.S. 
Division of Toxicology. Food and Drug Administration, U. S. Department of Health, Education, and Welfare, 
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The use of sensitization indices for expressing allergenic skin reactions in guinea pigs is 
described. The method is convenient for comparing allergens and cross-reacting substances 
and permits the use of both irritating and nonirritating challenge concentrations of allergens. 
It also permits determination of both optimal reading time and challenge concentrations for 
each experiment. By this technique commercial neomycin complex, neamine (neomycin Al, 
neomycin B, neomycin C. and streptomycin were found to be allergenic in guinea pigs via 
intradermal ( id) and foot-pad (fp) immunizations. The immunizing emulsion consisted of an 
allergen and an adjuvant containing Mycobacterium butyricum (MBl or Mycobacterium 
tuberculosis H37Ra (Ral. The adjuvant MB was as effective as Ra by the id route, but 
inferior to Ra by the fp route. 
The cross-reactivity of neomycin C was generally greater than neomycin B in guinea pigs 
sensitized to neamine. neomycin B, neomycin C. or streptomycin. In guinea pigs sensitized 
to neomycin complex by repeated immunizations, neomycins A. B, and C were effective 
elicitors of skin reactions, whereas the N-acetylated derivatives of the components failed 
to cause reactions. This finding is interpreted to mean that the amino groups of the amino-
glycosides are the coupling sites to host proteins in the processes of sensitization and 
elicitation of skin reactions in vivo. 
Aminoglycosides such as neomycin [1] and 
streptomycin [2] contain aminocyclitol (or amino-
inositol) and are produced by Streptomyces. They 
possess wide antibacterial activities against both 
gram-negative and gram-positive bacteria. Some 
of them are active against mycobacteria, and 
paromomycin is active against Entamoeba 
histolytica [3,4]. Some of these antibiotics cause 
delayed hypersensitivity reactions in humans and 
guinea pigs when applied by the topical route or 
injected by the intradermal (id) route [5-8]. They 
have been used as intestinal and skin antiseptics 
because they are not readily absorbed by the skin 
surface. or by the mucous or intestinal membranes 
[9, 10]. However, their usefulness as topical agents 
is reduced because of their capacity to cause 
contact sensitization, to cross-react with one an-
other [7.8,11-14]. and to be absorbed to a limited 
extent through skin [11]. 
Many of these antibiotics are mixtures of stereo-
isomers and closely related compounds. Some of 
them have not been separated from each other and 
full stereochemical structures are yet to be deter-
mined [15,16]. Commercial neomycin currently 
contains varying amounts of two stereoisomers, 
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neomycins B and C. Neomycin B is the major 
component and neomycin C is the minor compo-
nent, ranging from 10 to 34%. The latter has onl.v a 
third of the antibiotic activity of the former 
[17-19]. On hydrolysis both isomers yield neamine 
(or neomycin A. 2.6-diamino·n-glucopyranosyl-2-
deoxystreptamine ). As seen in the Figure, the other 
hydrolytic product is neobiosamine B or C (2,6-
diaminohexosyl-o-ribosel. depending on the start-
ing isomers [20-23]. 
In this paper we report: (l) the sensitization 
potentials of commercial neomycin complex. kana-
mycin, streptomycin. and neomycins A. B. and C 
in guinea pigs by using new rating methods; (2) the 
mutual cross-reactivity of these antibiotics. espe-
cially of neomycins and N -acety Ia ted derivatives of 
neomycins with neomycin complex. These investi· 
gations were conducted with the view toward 
understanding which reactive groups of these an-
tibiotics lead to antigen formation, and examining 
the immunologic adverse reactions in comparison 
with their antibiotic efficacy and other biologic 
effects. The new rating methods permitted the use 
of irritating concentrations of allergens for chal-
lenge and the selection of optimal reading time and 
challenge concentrations for each allergen or cross-
reacting substance. 
MATERIALS AND METHODS 
Male Hartley albino guinea pigs (300-400 gm) or both 
male and female guinea pigs of the English short-hair 
strain (450-550 gm) were used. They were fed Guinea Pig 
Chow from the Ralston Purina Company, St. Louis, Mo. 
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FIG. Structure of neomycins. 
Neomycin sulfate (complex, USP) was purchased from 
Schwarz/Mann, Orangeburg, N.Y. Kanamycin was ob-
t~ined from Bristol Laboratories, Syracuse, N.Y. Neomy-
cms A, B, and C, 2-deoxystreptamine and their N-
acetylated derivatives were gifts from Dr. Kenneth L. 
Rinehart, Jr., Department of Chemistry and Chemical 
Engineering. University of Illinois, Urbana, Ill. Freund's 
complete adjuvant containing heat-killed bacilli of either 
Mycobacterium butyricum (MB) or Mycobacterium 
tuberculosis H37Rs (Rs) was obtained from Difm Labo-
ratories, Detroit, Mich. The adjuvant was diluted to the 
desired concentration by adding the test allergen and 
Freund's incomplete adjuvant. 
The concentrations of all antibiotics or their deriva-
tives are expressed in terms of the free base, e.g .. 700 mg 
of free base per gram of neomycin sulfate on the basis of 
an assay. Desired amounts of these compounds were 
dissolved in saline, and an aliquot of the saline solution 
was mixed with an equal volume of adjuvant and 
emulsified prior to injection. For immunizations, 0.5 ml 
of the emulsion was distributed by id injection into 5 skin 
sites in the nuchal region or into each of the 4 foot-pads. 
Control guinea pigs received the emulsified adjuvant 
with saline but without the allergen. 
After a rest period of 9 to 28 days, all animals including 
the controls were challenged by id injections of several 
concentrations in saline of the allergen used for induc-
tion. When cross-reactions were studied. the inducer 
allergen and the cross-reacting substances were injected 
into the skin of the same animals in a volume of 0.05 ml 
per site. Both the experimental and the control animals 
were challenged in exactly the same manner. 
Skin erythema reactions were read at 24, 48, and 72 hr. 
The intensity of the reaction was rated from 0 to 6 
[24,25]. The reactions having ratings of 3 or higher were 
considered positive and those having ratings of 2 or less 
were considered negative. The following terms were used 
to express sensitization or elicitation potentials and 
immunologic cross-reactivity. 
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~ractional response (FR) is the number of positive 
antmals as related to the total number of animals used 
for each challenge concentration in each treated or con-
trol group. 
Net FR is the FR of the immunized group minus that 
of the control group. FRI is the fractional response index 
expressed in percent, and is calculated as follows: 
FRI ~ FR of treated - FR of controls x 100 
l - FR of controls 
Average erythema intensity (A[) is the ratio of the total 
numerical (erythema intensity) score to the total number 
of animals used per challenge concentration. All (average 
erythema intensity index) is expressed in a similar 
manner as FRI: 
All ~ AI of treated -AI of controls x 100 
6 - AI of controls 
FR is an all-or-none rating and in this paper it is used 
only to show the number of positive animals and the total 
number of animals used in each challenge dose. FRI 
values increase rapidly as compared with All values and 
soon reach the maximum value of 100, whereas All values 
are often near or less than 30. Therefore, FRI values are 
listed in the Tables in this paper to help interpretation of 
All values. All ratings are more valid than FR!s because 
of the involvement of all rating scores including 0 and the 
total number of the animals, and because the maximum 
rating score is .seldom reached. When the toxicity is high 
and the sens1t1zatwn potential is low, the validitv of this 
rating is low. · 
Values of FRI or All that were less than 15 were 
arbitrarily considered not significant. All values between 
15 and 19 were considered borderline. and ratings be-
tween 20 and 29 were considered as weak sensitizations. 
For convenience. ratings between 30 and 44 were arbi-
trarily considered as moderate sensitizations and ratings 
45 and above were considered as strong sensitizations. 
For statistical analysis only the All values were used. 
Although only limited data are presented in the Tables 
all All values were analyzed statistically for the particu: 
lar comparisons mentioned in the results. When the 
degree of sensitization of the treated animals was high, 
the values obtained from readings at 48 or 72 hr after 
challenge were more useful for final evaluations than 
those from readings at 24 hr. Especially, the readings at 
0.25 or 0.50% challenge concentrations were more mean-
ingful than those at 0.1 or 1.0%. because challenge 
concentrations that were too high were too toxic or 
inhibitory to the skin reactions, and because reactions 
produced by challenge doses that were too low faded 
away too quickly for optimal evaluations. When the 
treated guinea pigs showed very low sensitization rates 
the best readings at 24 hr after challenge were mor~ 
useful than those at 48 or 72 hr. A t-test was used for 
statistical analysis. 
RESULTS 
Effects of Adjuvants 
Immunization of guinea pigs by the id or foot-pad 
(fp) route with an emulsified mixture of 250 or 
2,000 1-'g of neomycin complex and the adjuvant 
containing 100 1-'g of Ra resulted in an appreciable 
sensitization rate when the id route was used for 
challenge (All in Tabs. I and IV). When the 
adjuvant Ra was replaced by MB, the sensitization 
rate was lower by the id route and appreciably 
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lower by the fp route (p < 0.025 at 0.1 and 0.5o/o 
challenge concentrations), as shown under Ail in 
Table I. When the degree of sensitization with 
neomycin complex was near the high range (the 
highest All, 43), the sensitized animals had appre-
ciable reactions to neomycins A, B, and C (Ra, id 
in Tab. 1). When the degree of sensitization was 
moderate (33) (MB, id in Tab. I), the animals had 
poor skin reactions to the individual components 
and, as compared with corresponding values (Ra, 
id in Tab. 1), both neomycins B and C caused 
significantly lower reactions (at least p < 0.05). 
When sensitization was low ( < 30) (MB, fp in Tab. 
1), the animals showed no appreciable skin reac-
tions to neomycins A, 8, and C. 
Therefore, when sensitization was low, the sensi-
tizer neomycin complex was a better eliciting 
allergen than any of the individual components, 
whereas each component was an equally good or a 
better elicitor of skin reactions at an equal concen-
tration when the sensitization rate was moderate or 
strong. 
Sensitization Rates with Different Immunization 
Routes 
When guinea pigs were immunized via the id 
route with adjuvant Ra, all individual neomycins 
caused moderate-to-strong sensitization indices 
except kanamycin, as seen in Table II. Kanamycin 
had a very low sensitization index. 
Neomycins B and C and streptomycin, given via 
Vol. 64, No. 3 
the fp route with Ra, caused moderate-to-strong 
sensitization, but immunization with neomycin A 
resulted in a negligible sensitization rate (Tab. Ill). 
When the adjuvant was Ra, both the id and the 
fp immunization routes sensitized guinea pigs 
equally well to the neomycins except for neomycin 
A. When the adjuvant was MB, the id route was 
generally better than the fp route (Tab. I). 
Cross-Reactivity Between the Neomycins via the 
fp Immunization Route 
As seen in Table III, the animals failed to have 
skin reactions to neomycin A, although they were 
immunized with neomycin A via the fp route with 
Ra. However. these animals showed cross-reactions 
to neomycin B and C and streptomycin (Ail in 
Tab. III). When neomvcin B was the inducer via 
the fp route, only neo~ycin C elicited cross-reac-
tions with neomycin B. When neomycin C was the 
inducer. both neomycin B and streptomycin 
caused cross-reactions but neomycin A did not. 
When streptomycin was the inducer, both neomy-
cins B and C caused cross-reactions but neomycin 
A again failed to cross-react. These results in Table 
III show that the fp immunization reduced cross-
reactivities, as observed in Table I. The cross-reac-
tivity of neomycin C to streptomycin was greater 
than that of neomycin B to streptomycin (p < 0.05 
at the challenge concentration of 0.5%). The cross-
reactivity of streptomycin to neomycin C was in a 
weak range, whereas that of neomycin B to strep-
tomycin was negligible (Tab. III). 
TABLE I. Effect of adjuvant species and immunization route on the sensitization potentials of neomycin complex and 
reactivity of the sensitized animals to the individual component antibiotics" 
Challenge Skin reactions at 48 hr 
Immunization route Ra (M. tuberculosis H37Ra) MB (M. butyricum) 
Substance Cone. rr:;r:) 
FR' FRI' All' FR' FRJ< All' 
Intradermal (id) Neomycin complex 0.1 16/22 73 43 11/20 51 28 
0.5 19/22 67 35 20/20 100 25 
1.0 22/22 NN 37 20/20 100 33 
Neomycin A 0.5 19/22 83 41 13/20 74 29 
NeomycinB 0.5 20/22 89 47 17/20 12 i 13 
Neomycin C 0.5 22/22 100 56 20/20 100 21 
Foot-pad (fp) Neomycin complex 0.1 19,22 85 48 9/20 25 24 
0.5 22/22 100 36 16/20 26 15 
1.0 20/22 0 30 15/20 7 15 
Neomycin A 0.5 11/22 22 8 7/20 0 0 
NeomycinB 0.5 21/22 96 50 15/20 0 0 
NeomycinC 0.5 21/22 95 49 17/20 0 4 
"Guinea pigs were immunized by id or fp injection of 250 !'g neomycin complex in a mixture of an adjuvant 
containing 100 )tg dry weight of either M. tuberculosis H37Ra (Ra) or M. butyricum (MB). After a rest period of 19 
days (Ra injections) or 13 days (MB injections), the immunized animals and control animals (that received only 
adjuvant alone) were challenged by id injection of the allergen (neomycin complex) and neomycins A, B, and C. 
'Fractional response (FR): Number of positive animals/total number of animals used. 
'Fractional response index (FRI) ~ (FR of treated ~ FR of controls)/(! ~ FR of controls) x 100. 
• All (Average intensity index) ~ (AI of treated ~ AI of controls)/(6 ~ AI of controls) x 100. AI (Average intensity) 
~ Sum of the numerical scores of skin reactions!fotal num her of animals used. 
• NA ~ Not applicable. 
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TABLE II. Cross-reactivities of neomycins and kanamycin to one another in the guinea pigs immunized and challenged 
by the intradermal (id) route" 
Challenge Skin reactions at 48 hr 
Immunizing substance 
Substance Cone.(%) FR FRI All 
Neomycin A (Neamine) 
Cross-reactions with: 
I 
Neomycin B 
I 
Cross-reactions with: 
I 
I 
Neomycin C I 
Cross-reactions with: 
Kanamycin 
Cross-reactions with: 
Neomycin A 
Neomycin B 
Neomycin C 
Kanamycin 
NeomycinB 
Neomycin A 
NeomycinC 
Kanamycin 
Neomycin C 
Neomycin A 
NeomycinB 
Kanamycin 
Kanamycin 
Neomycin A 
Neomycin B 
Neomycm C 
I 
I 
I 
I 
I 
i 
0.25 
0.50 
0.25 
0.50 
0.25 
0.50 
0.25 
0.50 
0.25 
0.50 
0.25 
0.50 
0.25 
0.50 
0.25 
0.50 
0.25 
0.50 
0.25 
0.50 
0.25 
0.50 
0.25 
0.50 
0.25 
0.50 
0.25 
0.50 
0.25 
0.50 
0.25 
0.50 
14/14 
14/14 
7/14 
5/14 
7/14 
13/14 
2/14 
2/14 
14/14 
11/14 
7/14 
12/14 
12/14 
14/14 
1/14 
0/14 
10/14 
14/14 
6/14 
8/14 
5/14 
8/14 
0/14 
0/14 
4/18 
9/18 
1/18 
11/18 
3/18 
1/18 
4/18 
8/18 
100 
100 
38 
26 
47 
89 
14 
14 
100 
75 
47 
83 
85 
100 
7 
0 
71 
100 
39 
47 
21 
50 
0 
0 
22 
50 
0 
52 
0 
0 
17 
ll 
54 
50 
11 
8 
27 
33 
5 
3 
53 
46 
24 
32 
49 
50 
0 
0 
39 
42 
12 
18 
11 
26 
0 
0 
8 
15 
0 
11 
0 
0 
7 
0 
'Guinea pigs were immunized with neomycin A (1 mg/animal). B, C, or kanamycin (2 rng/animal) in a mixture of 
an adjuvant containing 100 !'g of Ra by the id route. After 13 days of rest, the immunized and appropriate control 
animals were challenged by id injection with the allergen and cross-reacting substances, each in a separate site. For 
rating systems and symbols or abbreviations, see footnotes to Table I. 
Cross-Reactivity Between the Neomycin., via the 
id Immunization Route 
In the host guinea pigs that were immunized 
with neomycin A, neomycin C elicited a moderate 
cross-reactivity with neomycin A. whereas neomy-
cin B and kanamycin caused ne1;ligible cross-reac-
tions (All in Tab. II). The guinea pigs sensitized to 
neomycin B showed cross-reactions to neomycins A 
and C but no cross-reactions to kanamycin. When 
the animals were sensitized to neomycin C, they 
showed cross-reactions to neomycins A and B but 
no cross-reactions to kanamycin. When the ani-
mals were poorly sensitized to kanamycin, there 
were no cross-reactions to neomycins A, B, and C. 
The cross-reactivit~· of neomycin B with neomycin 
C was significantly less than that of neomycin C 
with neomycin B (p < 0.05 in Tab. II). Neomycin 
A elicited significantly less cross-reactivity with 
immunization via the fp route as compared with 
the id route for both Ra and MB (Tab. I). However, 
when the host animals were immunized via the fp 
route with neomycin complex and Ra and then 
reimmunized via the id route without an adjuvant, 
they showed an appreciable cross-reaction to 
neomycin A (Tab. IV). 
As seen from the above results, cross-reactivity 
depends on the nature of the allergen and the 
cross-reacting substance, the immunization route, 
and the degree of sensitization of the host to a 
particular allergen. The results also show that the 
cross-reactivity of neomycin B is less than that of 
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TABLE m. Mutual cross-reactivity of neomycin-sand streptomycin in the guinea pigs immunized by the foot-pad (fp) 
route" 
Challenge Skjn reactions at 24 hr 
Immunizing substance 
Substance Cone.(%) FR FRI All 
Neomycin A (Neamine) Neomycin A 0.50 0/10 0 7 
1.00 l/10 0 0 
Cross-reactions with: Neomycin B 0.50 l/10 10 17 
1.00 4/10 33 11 
Neomycin C 0.50 5/10 50 33 
1.00 7/10 67 6 
Streptomycin 0.50 5/10 50 32 
1.00 5/10 44 17 
Neomycin B NeomycinB 0.50 3/8 38 41 
1.00 6/8 72 43 
Cross-reactions with: Neomycin A 0.50 0/8 0 7 
1.00 0/8 0 11 
NeomycinC 0.50 4/8 50 48 
1.00 8/8 100 37 
Streptomycin 0.50 0/8 0 13 
1.00 1/8 3 5 
Neomycin C Neomycin C 0.50 8/9 89 59 
1.00 9/9 100 40 
Cross-reactions with: Neomycin A 0.50 0/9 0 2 
1.00 0/9 0 0 
NeomycinB 0.50 2/9 22 36 
1.00 7/9 76 30 
Streptomycin 0.50 2/9 22 21 
1.00 3/9 26 17 
Streptomycin Streptomycin 0.50 8/10 80 56 
1.00 10/10 100 51 
Cross-reactions with: Neomycin A 0.50 2/10 20 13 
1.00 2/10 13 0 
Neomycin B 0.50 3/10 30 24 
1.00 4/10 50 11 
!l<eomycinC 0.50 7/10 70 43 
1.00 8/10 60 17 
'Guinea pigs were immunized by fp injection of 2 mg of neomycin A, B, C, or streptomycin in a mixture of an 
adjuvant containing 100 l'g of Ra. After a rest period of 9 days the immunized and appropriate control animals were 
challenged by intradermal injection of neomycins A, B, C, and streptomycin in a saline solution. For rating systems 
and symbols or abbreviations, see footnotes to Table I. 
neomycin C or streptomycin whenever the experi-
mental elicitation reaction conditions are near 
optimal. 
Cross-Reactiuity of N-Acetylated Neamycins with 
Neomycin Complex 
The results in Table IV show that in guinea pigs 
sensitized to neomycin complex the intact neomy-
cins elicited appreciable cross-reactions, but the 
N-acetylated neomycins A, B, and C failed to 
cause anv cross-reactivitv. The cross-reactivities of 
the N-a~etylated deriv~tives, as compared with 
those of the parent compounds, were significantly 
less (at least p < 0.05 for challenge concentrations, 
except for neomycin A and N-acetyl neomycin A at 
the 1% challenge Ieveii. 
These results can be interpreted to mean that 
the amino groups are the coupling site to proteins 
lD VlVO. 
DISCUSSION 
An elicitation reaction of a host, following chal-
lenge with an allerl'enic agent, depends on many 
factors. When the agent is the inducing allergen, 
the degree of delayed hypersensitivity of the hosts 
and the challenge dose reaching the active site 
appear to be most important. If the amount of 
allergenic agent is either zero or below the thresh-
old value, no skin reactions will be elicited. When 
the host immunity is high. even the low doses that 
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TABLE IV. Cross-reactivity of neomycins and 
N-acetylated neomycins to neomycin complex in guinea 
pigs immunized by the foot-pad (fp) route" 
Challenging substance 
:\!eomycin complex 
:\!eomycin A 
Neomycin B 
Neomycin C 
Neomycin complex 
N-Acetyl-neomycin A 
N-Acetyl-neomycin B 
N-Acetyl-neomycin C 
Challenge 
cone. 
(%) 
0.5 
1.0 
0.5 
1.0 
0.5 
1.0 
0.5 
1.0 
0.5 
1.0 
0.5 
1.0 
0.5 
1.0 
Skin reaction at 48 h:r 
FR 
12/12 
12/12 
6/12 
11/12 
12/12 
12/12 
12/12 
12/12 
11/11 
11/11 
2/ll 
2/11 
0/11 
0/11 
FRI 
100 
100 
50 
89 
100 
100 
100 
100 
100 
100 
18 
0 
0 
0 
All 
51 
43 
.33 
42 
50 
50 
58 
55 
44 
34 
6 
10 
6 
5 
0 
0 
o Guinea pigs were immunized with a mixture of an 
adjuvant (Ra. 100 ~tgl and neomycin complex (2 mg/ani-
ma]) by the fp route. The animals were challenged to 
confirm sensitization to neomycin complex after a rest 
period of 2 weeks. Four weeks after the first challenge. 
they were rechallenged by the intradermal (idl injection 
of above substances for cross~reactivity. For rating sys-
tems and abbreviations. see footnotes to Table I. 
produce no skin reactions in the control animals 
will elicit a strong skin reaction in the treated ani-
mals. ~nen the immunity of the host is low. onlv 
high challenge doses elicit skin reactions. The sig-
nificance of these latter react ions can only be as-
certained by statistical means. because most of the 
erythema reactions are due to irritation or toxicitv 
of the agent rather than to the allergic response.· 
The scoring and rating procedures presented in 
this paper are further modifications of those previ-
ously described [24,25]. The modifications involve 
indexing to improve the data handling for com-
parative studies. Two forms of indices were em-
ployed: one for fractional response (FR). and a 
second for average intensity (AI). Each of these has 
its own advantages and disadvantages. The index 
for the average intensity rating is the more reliable 
of the two in a wide range of challenge concentra-
tions because of the involvement of all the animals 
and all the scores. The index for FR is listed to help 
in the interpretation of the results. FR was used 
frequently in the past but it shows only the number 
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of positive animals and the total number of ani-
mals used. 
Epstein and Wenzel [8] used 0.1 ml of 1% 
neomycin sulfate in saline solution for id challenge. 
This concentration is an irritating concentration 
with fairly strong positive reactions in almost all 
controls. We were unable to ascertain sensitization 
at this high challenge dose without use of the 
indices. Even 0.05 ml of 0.25 or 0.5% neomvcin 
complex in saline solution caused positive ~kin 
reactions in controls. Raab [12] has questioned the 
usefulness of the id tests of Epstein and Wenzel in 
the diagnosis of sensitization, and the controversv 
seems to be unsettled [11 ]. When the hosts wer~ 
highly sensitized. it was possible for an ex-
perienced rater or dermatologist to see the differ-
ence between the strongly sensitized and the con-
trol sites at this high challenge concentration. In 
weakly-to-moderately sensitized hosts, the visual 
rating was not useful without indexing or statisti-
cal analysis. The findings of Epstein and Wenzel 
[8] should not be considered in conflict with our 
findings reported in this paper. Findings in agree-
ment are: (1) neomycin complex and streptomycin 
are allergenic in guinea pigs: ( 2) cross-reactivitv 
with other related substances are dependent on th~ 
degree of immunity of the hosts; and (3} irritating 
concentrations of allergens can be used for chal-
lenge when the rater is highly experienced in visual 
rating or a proper rating method is used for 
evaluation. Epstein and Wenzel failed to sensitize 
guinea pigs to kanamycin or dihydrostreptomycin, 
whereas we were successful most of the time but 
not always. They used doses for immunization that 
were too high or too low and a rest period of on! v 1 
week. We employed near-optimal doses for im~u­
nization and 2 or more challenge concentrations, 1 
of which was close to the optimal concentration, 
and a rest period of 2 or more weeks. 
The N -acety lated derivatives of neomvcins A, B, 
and C failed to cross-react with neomyci~ complex, 
whereas neomycins A. B. and C elicited apprecia-
ble skin reactions on challenge in the guinea pigs 
sensitized by repeated injections of neomycin com-
plex. This finding suggests that. in the processes of 
induction of sensitization and elicitation of skin 
reactions, the active sites of neomvcins for cou-
pling to the skin protein are the amiu"o groups. This 
finding is very similar to the observations of Nitti, 
Bovet, and Depierre [26] that N-acetylation or 
replacement of one of the two amino groups of 
para-phenylenediamine with a methvl, hvdroxvl, 
or aminosulfonyl group reduced the -sensitizati~n 
rate of the chemical drasticallv. 
That the cross-reactivitv of neomvcin C to its 
stereoisomer. neomycin B, is gre~ter than to 
neomycin C (Tabs. I-III) is of great interest, 
although neomycin C was not significantly more 
sensitizing than neomycin B. 
The authors gratefully acknowledge the generous gifts 
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ment of Chemistry and Chemical Engineering, Univer-
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